Altasciences completes acquisition of US-based CRO WCCT Global
Mid-size CRO/CDMO Altasciences has acquired early-stage clinical research organisation (CRO) WCCT Global. WCCT is located in southern California on the…
Mid-size CRO/CDMO Altasciences has acquired early-stage clinical research organisation (CRO) WCCT Global. WCCT is located in southern California on the…
Private equity investment firm GI Partners has announced the completion of the acquisition of global clinical trial technology firm Clinical…
Irish company ICON has agreed to acquire contract research company PRA Health Sciences in a cash and stock deal valued at about $12bn. The acquisition…
Stealth BioTherapeutics has completed enrolment in the Phase II ReCLAIM-2 study (SPIAM-202) of its lead product candidate, elamipretide, in patients with dry age-related macular degeneration…
NeuroRx has reported that the Phase IIb/III trial of Zyesami (aviptadil, previously RLF-100) showed multidimensional benefit in treating respiratory failure…
Yale School of Medicine has announced a randomised clinical trial led by the Yale Cardiovascular Research Group (YCRG) to study…
Specialty biopharmaceutical company RedHill Biopharma is set to expand its global Phase II/III study of opaganib in patients with severe…
Speciality biopharmaceutical company Adamis Pharmaceuticals is set to proceed with the Phase II/III study of Tempol (MBM-02) for treating Covid-19.…
UKONIQ™ (umbralisib) is the first and only oral, dual inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
In the past few months, two new warehouses were erected and put into operation on the IKA premises. IKA continues…
The global MedTech outsourcing market has ballooned as businesses look for ways to improve patient care while streamlining their own…